Empirical studies in applied economics

XIV, 211 S.

graph. Darst.

Includes bibliographical references and index

Machine generated contents note: I. REVEALED MARKET POWER OF A NATURAL GAS PIPELINE -- 1.1 Introduction -- 1.2 Basis Differentials -- 1.3 Discounting -- 1.3.1 The Data Assembled -- 1.3.2 Analysis -- 1.3.3 Transaction Data Analysis -- 1.4 Econometric Results -- 1.5 Conclusion -- THE DEMAND FOR NFL FOOTBALL -- 2.1 Introduction -- 2.2 The Demand for NFL Football Tickets -- 2.3 Bandwagons, Social Influences, and Group Demand -- 2.4 Becker's Model -- 2.5 The Demand for NFL Football -- X Conclusions -- IlF'S IN THE DEMAND FOR DIRECT MAIL -- Introduction -- Comparison of Original, Revised, and Updated Direct Mail -- Models -- 2.1 Comparison of Revised and Updated Models -- 2.2 Addressed Admail-Specific Results -- 3.3 The Shift in Demand Between 1I95 and 1996 -- 3.4 Comparing Forecast Accuracy -- 3.4.1 Forecasting Addressed Admail Volume -- 3.4.2 Measures of Forecast Accuracy -- 3.4.3 Forecast Results-Confidence Intervals -- 3.4.4 Forecast Results-Conclusions -- 4. VALUATION OF A TECHNOLOGY PATENT -- 4.1 Introduction -- 4.2 Scope Limitations -- 4.2.1 The Variety of Computer Upgrade Technologies -- 4.2.2 Coprocessors and Empty Slots -- 4.2.3 Proprietary Upgrade Methods -- 4.2.4 Dual-Socket Technology Was Rare -- 4.3 Duration Limitations -- 4.3.1 A Product Lifecycle Model for CPU Sales -- 4.4 Limitations in the Royalty's Value -- 4.4.1 The Presence of Non-Infringing Substitutes Limits the -- Value of a Patent -- 4.4.2 The Value of a Consumer Upgrade Option -- 4.4.3 Trademark and Patent Valuation -- 4.5 Conclusions -- 5. STATISTICAL ANALYSIS OF SYNERGY -- 5.1 introduction -- 5.2 Case-Control Studies -- 5.2.1 Tests for Case-Control Studies-Multiplicative Case -- 5.2.2 Woolf's Method -- 5.2.3 Tests for Case-Control Studies-Additive Case -- 5.2.4 Maximum Likelihood -- 5.3 Bonferroni Intervals and Simulations -- 5.3.1 Bonferroni Interval -- 5.3.2 Simulation Methods -- 5.4 Synergy Indices -- 5.4.1 Rothman's S Index -- 5.4.2 Attributable Proportion Index -- 5.4.3 Additive-Multiplicative Measure -- 5.5 Cohort Studies -- 5.5.1 Determination of Death Rates -- 5.5.2 Variance of the Additive and Multiplicative Statistics -- 5.5.3 Variance of the Synergy Index -- 5.6 Conclusion -- 6. TESTS OF SYNERGY -- 6.1 Introduction -- 6.2 Review of Studies -- 6.2.1 Hammond, Selikoff, and Seidman (1979) -- 6.2.2 Selikoff, Seidman, and Hammond (1980) -- 6.2.3 Berry, Newhouse, and Turok (1972) -- 6.2.4 Berry, Newhouse, and Antonis (1985) -- 6.2.5 McDonald, Liddell, et al. (1980) -- 6.2.6 Liddell, Thomas, et al. (1984) -- 6.2.7 Martischnig, Newell, et al. (1977) -- 6.2.8 Pastorino, Bearino, etal. (1984) -- 6.2.9 deKlerk, Musk, etal. (1991) -- 6.2.10 Bovenzi, Stanta, et al. (1993) -- 6.2.11 Blot, Harrington, etal. (1978) -- 6.2.12 Blot, Morris, etal. (1980) -- 6.2.13 Kjuus, Skjaerven, et al. (1986) -- 6.2.14 Vena, Byers, et al. (1985) -- 6.3 Tests of Hypothesis -- 6.3.1 Hammond, Selikoff, and Seidman (1979) -- 6.3.2 deKlerk, et al (1991) -- 6.4 Meta-analysis of the Fourteen Synergy Studies -- 6.5 Conclusions -- CONCENTRATION IN THE CHEMOTHERAPY DRUG MARKET -- 7.1 Introduction -- 7.2 Market Structure -- 7.2.1 R&D Economies of Scale -- 7.2.2 Monopoly Power from Statutory Exclusivity -- 7.2.3 Brand Loyalty -- 7.2.4 Generic Drug Introduction -- 7.2.5 Creating and Maintaining a Monopoly -- 7.3 Statutory Exclusivity in the United States -- 7.3.1 Pure Food and Drug Act of 1906 and Food, Drug and -- Cosmetic Act of 1938 -- 7.3.2 1983 Orphan Drug Act -- 7.3.3 Drug Price Competition and Patent Restoration Act of -- 1984 -- 7.3.4 Exclusive Government Agency Licenses -- 7.4 History of Paclitaxel -- 7.5 Market Power Measures -- 7.5.1 Herfindahl-Hirschman Index (HHI) -- 7.5.2 Weighted HHI -- 7.5.3 Weighted Market Share Statistic -- 7.5.4 Market Share Weighted HHI -- 7.6 The Relevant Product Market for Paclitaxel Drugs -- 7.6.1 Antitrust Markets -- 7.6.2 Market Delineation-Demand Substitutability -- 7.6.3 Market Delineation-Supply Substitutability -- 7.6.4 The Relevant Product Market for Taxane Drugs -- 7.6.5 HHls-Market Concentration Results -- 7.6.6 Market Share Weighted HHI -- 7.7 Conclusion -- 8. ALASKAN POLICE SERVICES -- 8.1 Introduction -- 8.2 Historical Background -- 8.3 Theory -- 8.4 Allocation Analysis -- 8.4.1 The Dataset -- 8.4.2 Analysis of Variance -- 8.4.3 Econometric Model -- 8.5 Conclusions -- 9. FAST FOOD HEALTH SCARE -- 9.1 Introduction -- 9.2 Data Sources -- 9.2.1 Restaurant Trends Data -- 9.2.2 Bureau of Economic Analysis -- 9.2.3 National Income and Product Accounts -- 9.2.4 Bureau of Labor Statistics -- 9.3 Econometric Models -- 9.3.1 Revenue per Capita -- 9.3.2 Average Unit Volume -- 9.3.3 Stores per Capita -- 9.4 Simulations and Conclusions -- 9.4.1 Market Share Logit Model -- 9.4.2 Conclusions -- Index

ECONIS - Online Catalogue of the ZBW